Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;89:615-622

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stratmann, H. G.
Right arrow Articles by Miller, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stratmann, H. G.
Right arrow Articles by Miller, D. D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Chest Pain

Circulation, Vol 89, 615-622, Copyright © 1994 by American Heart Association


ARTICLES

Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain

HG Stratmann, GA Williams, MD Wittry, BR Chaitman and DD Miller
Division of Cardiology, St Louis Veterans Administration Medical Center, Mo.

BACKGROUND: This study was designed to evaluate the prognostic value of symptom-limited maximal exercise treadmill testing with tomographic technetium-99m sestamibi (MIBI) myocardial imaging in patients referred for evaluation of stable angina. Exercise stress thallium-201 myocardial imaging provides prognostic information in coronary artery disease subsets including patients with stable chest pain. The prognostic value of exercise technetium-99m MIBI myocardial tomography has not been established. METHODS AND RESULTS: Of 548 consecutive patients with stable angina pectoris who underwent maximal exercise treadmill stress testing in combination with a same-day "rest-stress" tomographic technetium-99m MIBI myocardial imaging protocol, 521 patients were followed for 13 +/- 5 months to determine the univariate and multivariate variables associated with cardiac events and to define their cardiac event-free survival. Ten patients were lost to follow-up (98% complete), and 17 who had coronary revascularization within 6 months of testing were excluded. Major cardiac events occurred in 24 patients (9%)--nonfatal myocardial infarction in 11 and cardiac death in 13. Univariate Cox survival analysis demonstrated significant relative risk (RR) and 95% confidence intervals (CI) for exercise ST segment depression (RR = 2.3; 95% CI, 1.0 to 5.3), an abnormal MIBI scan (RR = 13.8; 95% CI, 1.9 to 102.3), and a reversible MIBI perfusion defect (RR = 3.2; 95% CI, 1.4 to 7.5). Multivariate models demonstrated that both exercise MIBI perfusion abnormalities (RR = 11.9; 95% CI, 1.6 to 89.4) and reversible MIBI perfusion defects (RR = 2.9; 95% CI, 1.2 to 7.0) had independent predictive value. During 1 year of follow-up, cardiac events occurred in only 0.5% of patients with normal MIBI scans compared with 7% of those with abnormal MIBI scans (P < .001). One- year, cardiac event-free survival was 92% in patients with reversible MIBI perfusion defects (P < .01 versus normal), 96% in patients with fixed defects (P < .01), and 93% in patients with combined reversible and fixed MIBI myocardial perfusion abnormalities (P < .02). CONCLUSIONS: As with exercise thallium-201 myocardial imaging, exercise stress technetium-99m MIBI myocardial tomography provides significant independent information concerning the subsequent risk of serious cardiac events (death, myocardial infarction) in patients with stable angina pectoris. The identification of MIBI perfusion abnormalities, in particular, the presence of reversible MIBI defects, was associated with reduced 1-year, event-free survival. The recognized imaging and radiotracer biokinetic differences between thallium-201 and MIBI do not appear to modulate the prognostic value associated with scintigraphic evidence of ischemic myocardial jeopardy in the stable angina population.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. M. van Werkhoven, J. D. Schuijf, O. Gaemperli, J. W. Jukema, E. Boersma, W. Wijns, P. Stolzmann, H. Alkadhi, I. Valenta, M. P.M. Stokkel, et al.
Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease.
J. Am. Coll. Cardiol., February 17, 2009; 53(7): 623 - 632.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
R. J. Gibbons
Noninvasive Diagnosis and Prognosis Assessment in Chronic Coronary Artery Disease: Stress Testing With and Without Imaging Perspective
Circ Cardiovasc Imaging, November 1, 2008; 1(3): 257 - 269.
[Full Text] [PDF]


Home page
CirculationHome page
J. H. Mieres, L. J. Shaw, A. Arai, M. J. Budoff, S. D. Flamm, W. G. Hundley, T. H. Marwick, L. Mosca, A. R. Patel, M. A. Quinones, et al.
Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Coronary Artery Disease: Consensus Statement From the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association
Circulation, February 8, 2005; 111(5): 682 - 696.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Hachamovitch, S. W. Hayes, J. D. Friedman, I. Cohen, and D. S. Berman
Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD
J. Am. Coll. Cardiol., January 21, 2004; 43(2): 200 - 208.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N K Sabharwal and A Lahiri
Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease
Heart, November 1, 2003; 89(11): 1291 - 1297.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. F.L. Schinkel, A. Elhendy, R. T. van Domburg, J. J. Bax, J. R.T.C. Roelandt, and D. Poldermans
Prognostic Value of Dobutamine-Atropine Stress 99mTc-Tetrofosmin Myocardial Perfusion SPECT in Patients with Known or Suspected Coronary Artery Disease
J. Nucl. Med., June 1, 2002; 43(6): 767 - 772.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. D. Miller
Coronary flow studies for risk stratification in multivessel disease: A physiologic bridge too far?
J. Am. Coll. Cardiol., March 6, 2002; 39(5): 859 - 863.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A. Calnon, P. D. McGrath, A. L. Doss, F. E. Harrell Jr, D. D. Watson, and G. A. Beller
Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1511 - 1517.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. V. Williams, S. D. Fihn, and R. J. Gibbons
Guidelines for the Management of Patients with Chronic Stable Angina: Diagnosis and Risk Stratification
Ann Intern Med, October 2, 2001; 135(7): 530 - 547.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Wei, E. Le, J.-P. Bin, M. Coggins, A. R. Jayawera, and S. Kaul
Mechanism of reversible 99mTc-sestamibi perfusion defects during pharmacologically induced vasodilatation
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1896 - H1904.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Hoffmann, H. Lethen, H. Kuhl, W. Lepper, and P. Hanrath
Extent and severity of test positivity during dobutamine stress echocardiography. Influence on the predictive value for coronary artery disease
Eur. Heart J., October 2, 1999; 20(20): 1485 - 1492.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
P. Y. Marie, N. Danchin, F. Branly, M. Angioi, A. Grentzinger, J. M. Virion, B. Brouant, P. Olivier, G. Karcher, Y. Juilliere, et al.
Effects of medical therapy on outcome assessment using exercise thallium-201 single photon emission computed tomography imaging: Evidence of a protective effect of beta-blocking antianginal medications
J. Am. Coll. Cardiol., July 1, 1999; 34(1): 113 - 121.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al.
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197.
[Full Text] [PDF]


Home page
ChestHome page
B. P. Mandalapu, M. Amato, and H. G. Stratmann
Technetium Tc 99m Sestamibi Myocardial Perfusion Imaging: Current Role for Evaluation of Prognosis
Chest, June 1, 1999; 115(6): 1684 - 1694.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. J. Shaw, R. Hachamovitch, D. S. Berman, T. H. Marwick, M. S. Lauer, G. V. Heller, A. E. Iskandrian, K. L. Kesler, M. I. Travin, H. C. Lewin, et al.
The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia
J. Am. Coll. Cardiol., March 1, 1999; 33(3): 661 - 669.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. N. Chatziioannou, W. H. Moore, P. V. Ford, R. E. Fisher, V.-V. Lee, C. Alfaro-Franco, and R. D. Dhekne
Prognostic Value of Myocardial Perfusion Imaging in Patients With High Exercise Tolerance
Circulation, February 23, 1999; 99(7): 867 - 872.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. Berman, X. Kang, K. F. Van Train, H. C. Lewin, I. Cohen, J. Areeda, J. D. Friedman, G. Germano, L. J. Shaw, and R. Hachamovitch
Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography
J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1987 - 1995.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Iskander and A. E. Iskandrian
Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging
J. Am. Coll. Cardiol., July 1, 1998; 32(1): 57 - 62.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. L. Geleijnse, A. Elhendy, R. T. van Domburg, J. H. Cornel, R. Rambaldi, A. Salustri, A. E. M. Reijs, J. R. T. C. Roelandt, and P. M. Fioretti
Cardiac Imaging for Risk Stratification With Dobutamine-Atropine Stress Testing in Patients With Chest Pain : Echocardiography, Perfusion Scintigraphy, or Both?
Circulation, July 1, 1997; 96(1): 137 - 147.
[Abstract] [Full Text]


Home page
CirculationHome page
R. Hachamovitch, D. S. Berman, H. Kiat, I. Cohen, J. A. Cabico, J. Friedman, and G. A. Diamond
Exercise Myocardial Perfusion SPECT in Patients Without Known Coronary Artery Disease : Incremental Prognostic Value and Use in Risk Stratification
Circulation, March 1, 1996; 93(5): 905 - 914.
[Abstract] [Full Text]